Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines Pharmaceutical Investing
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Pharmaceutical Investing
BioCure Announces a Contract with Osong Hi-Tech Medical Industry Promotion Foundation Biotech Investing
Menlo Therapeutics’ Phase 2 Serlopitant Study for the Treatment of Chronic Pruritus Published in Journal Pharmaceutical Investing
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma Biotech Investing
Pernix Therapeutics Launches Generic Version of Treximet by Company’s Subsidiary, Macoven Pharmaceuticals Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
